OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Assessment of the Impact of Tardive Dyskinesia in Clinical Practice: Consensus Panel Recommendations
Richard Jackson, Matthew Brams, Leslie Citrome, et al.
Neuropsychiatric Disease and Treatment (2021) Vol. Volume 17, pp. 1589-1597
Open Access | Times Cited: 47
Richard Jackson, Matthew Brams, Leslie Citrome, et al.
Neuropsychiatric Disease and Treatment (2021) Vol. Volume 17, pp. 1589-1597
Open Access | Times Cited: 47
Showing 1-25 of 47 citing articles:
Pathophysiology, prognosis and treatment of tardive dyskinesia
Hiroyoshi Takeuchi, Yasuhiro Mori, Yuichiro Tsutsumi
Therapeutic Advances in Psychopharmacology (2022) Vol. 12
Open Access | Times Cited: 29
Hiroyoshi Takeuchi, Yasuhiro Mori, Yuichiro Tsutsumi
Therapeutic Advances in Psychopharmacology (2022) Vol. 12
Open Access | Times Cited: 29
Lurasidone-Induced Tardive Dyskinesia Reversed With Lithium Therapy: A Case Report
Alice Gelman, Tamar Jacobsohn, Hyon‐Seung Yi, et al.
Journal of Pharmacy Practice (2025)
Closed Access
Alice Gelman, Tamar Jacobsohn, Hyon‐Seung Yi, et al.
Journal of Pharmacy Practice (2025)
Closed Access
A Validation Study of The Clinician’s Tardive Inventory (CTI)
Richard Trosch, Alicia C. Shillington, Cynthia L. Comella, et al.
Parkinsonism & Related Disorders (2025), pp. 107812-107812
Closed Access
Richard Trosch, Alicia C. Shillington, Cynthia L. Comella, et al.
Parkinsonism & Related Disorders (2025), pp. 107812-107812
Closed Access
The Tardive Dyskinesia Impact Scale (TDIS), a novel patient-reported outcome measure in tardive dyskinesia: development and psychometric validation
Robert Farber, Donald E. Stull, Brooke Witherspoon, et al.
Journal of Patient-Reported Outcomes (2024) Vol. 8, Iss. 1
Open Access | Times Cited: 2
Robert Farber, Donald E. Stull, Brooke Witherspoon, et al.
Journal of Patient-Reported Outcomes (2024) Vol. 8, Iss. 1
Open Access | Times Cited: 2
Efficacy and safety of Transcranial Direct Current Stimulation (tDCS) on cognitive function in chronic schizophrenia with Tardive Dyskinesia (TD): a randomized, double-blind, sham-controlled, clinical trial
Yue Zhou, Xingzhi Xia, Xueli Zhao, et al.
BMC Psychiatry (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 5
Yue Zhou, Xingzhi Xia, Xueli Zhao, et al.
BMC Psychiatry (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 5
Tardive Dyskinesia: Addressing the Challenges of an Iatrogenic Movement Disorder
M. Nur E. Alam, Kashif Abbas, N. Usmani, et al.
International Journal of Biochemistry & Physiology (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 1
M. Nur E. Alam, Kashif Abbas, N. Usmani, et al.
International Journal of Biochemistry & Physiology (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 1
Impact-Tardive Dyskinesia (Impact-TD) Scale
Richard F. W. Jackson, Matthew Brams, Noelle E. Carlozzi, et al.
The Journal of Clinical Psychiatry (2022) Vol. 84, Iss. 1
Open Access | Times Cited: 6
Richard F. W. Jackson, Matthew Brams, Noelle E. Carlozzi, et al.
The Journal of Clinical Psychiatry (2022) Vol. 84, Iss. 1
Open Access | Times Cited: 6
Bacillus Calmette–Guérin Vaccine Attenuates Haloperidol-Induced TD-like Behavioral and Neurochemical Alteration in Experimental Rats
Narhari Gangaram Yedke, Shubham Upadhayay, Randhir Singh, et al.
Biomolecules (2023) Vol. 13, Iss. 11, pp. 1667-1667
Open Access | Times Cited: 3
Narhari Gangaram Yedke, Shubham Upadhayay, Randhir Singh, et al.
Biomolecules (2023) Vol. 13, Iss. 11, pp. 1667-1667
Open Access | Times Cited: 3
Efficacy and safety of Transcranial Direct Current Stimulation (tDCS) on Cognitive Function in Chronic Schizophrenia with Tardive Dyskinesia (TD): a randomized, double-blind, sham-controlled, clinical trial
Yue Zhou, Xingzhi Xia, Xueli Zhao, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 2
Yue Zhou, Xingzhi Xia, Xueli Zhao, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 2
Chapter 15. Eating Disorders and Body Image Satisfaction in Transgender, Non-binary, and/or Gender-Expansive (TNG) People
American Psychiatric Association Publishing eBooks (2023), pp. 215-228
Closed Access | Times Cited: 2
American Psychiatric Association Publishing eBooks (2023), pp. 215-228
Closed Access | Times Cited: 2
The Clinical and Economic Burden of Tardive Dyskinesia in Israel
Yael Barer, Rinat Ribalov, Ayelet Yaari, et al.
Journal of Clinical Psychopharmacology (2022) Vol. 42, Iss. 5, pp. 454-460
Open Access | Times Cited: 3
Yael Barer, Rinat Ribalov, Ayelet Yaari, et al.
Journal of Clinical Psychopharmacology (2022) Vol. 42, Iss. 5, pp. 454-460
Open Access | Times Cited: 3
Telehealth for Assessing and Managing Tardive Dyskinesia: Expert Insights from a Cross-Disciplinary Virtual Treatment Panel
Rif S. El‐Mallakh, Amy Belnap, Sanjay Iyer, et al.
Telemedicine Journal and e-Health (2022) Vol. 29, Iss. 7, pp. 1096-1104
Open Access | Times Cited: 3
Rif S. El‐Mallakh, Amy Belnap, Sanjay Iyer, et al.
Telemedicine Journal and e-Health (2022) Vol. 29, Iss. 7, pp. 1096-1104
Open Access | Times Cited: 3
Current perspectives on the epidemiology and burden of tardive dyskinesia: a focused review of the clinical situation in Japan
Yasuhiro Mori, Hiroyoshi Takeuchi, Yuichiro Tsutsumi
Therapeutic Advances in Psychopharmacology (2022) Vol. 12
Open Access | Times Cited: 3
Yasuhiro Mori, Hiroyoshi Takeuchi, Yuichiro Tsutsumi
Therapeutic Advances in Psychopharmacology (2022) Vol. 12
Open Access | Times Cited: 3
Chapter 2. Stigma and Mental Health Inequities
American Psychiatric Association Publishing eBooks (2023), pp. 15-30
Closed Access | Times Cited: 1
American Psychiatric Association Publishing eBooks (2023), pp. 15-30
Closed Access | Times Cited: 1
Sustained Treatment Response and Global Improvements With Long-term Valbenazine in Patients With Tardive Dyskinesia
Christoph U. Correll, Leslie Citrome, Carlos Singer, et al.
Journal of Clinical Psychopharmacology (2024)
Open Access
Christoph U. Correll, Leslie Citrome, Carlos Singer, et al.
Journal of Clinical Psychopharmacology (2024)
Open Access
Analysis of Antipsychotic Dosage in Patients With Tardive Dyskinesia: A Case-Control Study Using the Claims Database of the Corporate Health Insurance Association
M. Wafik Gouda, M. Abe, Yumi Watanabe, et al.
Journal of Clinical Psychopharmacology (2024)
Open Access
M. Wafik Gouda, M. Abe, Yumi Watanabe, et al.
Journal of Clinical Psychopharmacology (2024)
Open Access
Switching a combination of first- and second-generation antipsychotic polypharmacy to antipsychotic monotherapy in long-term inpatients with schizophrenia and related disorders. The SwAP trial II: Results on side effects
Mushde Shakir, Peter N. van Harten, Adriaan W. Hoogendoorn, et al.
Schizophrenia Research (2024) Vol. 274, pp. 105-112
Closed Access
Mushde Shakir, Peter N. van Harten, Adriaan W. Hoogendoorn, et al.
Schizophrenia Research (2024) Vol. 274, pp. 105-112
Closed Access
Neuroprotection by arbutin against haloperidol-induced Tardive Dyskinesia in rats and reducing neurotoxicity in SHSY-5Y cells
Gursewak Singh, Shubham Upadhayay, Umashanker Navik, et al.
Research Square (Research Square) (2022)
Open Access | Times Cited: 2
Gursewak Singh, Shubham Upadhayay, Umashanker Navik, et al.
Research Square (Research Square) (2022)
Open Access | Times Cited: 2
Exploring real-world symptom impact and improvement in well-being domains for tardive dyskinesia in VMAT2 inhibitor-treated patients via clinician survey and chart review
Jonathan M. Meyer, Craig Chepke, Rimal Bera, et al.
Mental Health Clinician (2023) Vol. 13, Iss. 5, pp. 225-232
Open Access
Jonathan M. Meyer, Craig Chepke, Rimal Bera, et al.
Mental Health Clinician (2023) Vol. 13, Iss. 5, pp. 225-232
Open Access
Regional Homogeneity in schizophrenia patients with tardive dyskinesia: a resting-state fMRI study
Ting Yu, Yanli Li, Na Li, et al.
Psychiatry Research Neuroimaging (2023) Vol. 335, pp. 111724-111724
Closed Access
Ting Yu, Yanli Li, Na Li, et al.
Psychiatry Research Neuroimaging (2023) Vol. 335, pp. 111724-111724
Closed Access
Chapter 3. (Rethinking) the Neuroscience of Gender Identity
American Psychiatric Association Publishing eBooks (2023), pp. 31-47
Closed Access
American Psychiatric Association Publishing eBooks (2023), pp. 31-47
Closed Access
Chapter 23. Collecting and Analyzing Gender Identity Data to Enhance Your Practice
American Psychiatric Association Publishing eBooks (2023), pp. 321-331
Closed Access
American Psychiatric Association Publishing eBooks (2023), pp. 321-331
Closed Access
Chapter 25. Legal and Policy Considerations for Gender-Affirming Mental Health Care
American Psychiatric Association Publishing eBooks (2023), pp. 347-354
Closed Access
American Psychiatric Association Publishing eBooks (2023), pp. 347-354
Closed Access
Chapter 14. Caring for the Mental Health Needs of Transgender, Non-binary, and/or Gender-Expansive (TNG) Older Adults
American Psychiatric Association Publishing eBooks (2023), pp. 201-214
Closed Access
American Psychiatric Association Publishing eBooks (2023), pp. 201-214
Closed Access
